Zurich Cantonal Bank
BBIO icon

Zurich Cantonal Bank’s BridgeBio Pharma BBIO Stock Holding History

Zurich Cantonal Bank’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.5M Buy
73,893
+7,906
+12% +$554K 0.01% 663
2026
Q1 		$4.9M Buy
65,987
+11,689
+22% +$847K 0.01% 658
2025
Q4 		$4.15M Buy
54,298
+13,379
+33% +$878K 0.01% 675
2025
Q3 		$2.13M Buy
40,919
+3,447
+9% +$168K ﹤0.01% 891
2025
Q2 		$1.62M Buy
37,472
+5,850
+18% +$213K ﹤0.01% 969
2025
Q1 		$1.09M Buy
31,622
+92
+0.3% +$3.1K ﹤0.01% 1113
2024
Q4 		$865K Buy
31,530
+6,466
+26% +$167K ﹤0.01% 1278
2024
Q3 		$638K Sell
25,064
-8
-0% -$210 ﹤0.01% 1407
2024
Q2 		$635K Buy
25,072
+3,122
+14% +$85.4K ﹤0.01% 1322
2024
Q1 		$679K Buy
21,950
+1,320
+6% +$44.9K ﹤0.01% 1285
2023
Q4 		$833K Buy
20,630
+3,139
+18% +$94.3K ﹤0.01% 1177
2023
Q3 		$461K Hold
17,491
– – ﹤0.01% 1449
2023
Q2 		$301K Buy
17,491
+3,356
+24% +$50.5K ﹤0.01% 1674
2023
Q1 		$234K Hold
14,135
– – ﹤0.01% 1771
2022
Q4 		$108K Buy
14,135
+4,038
+40% +$38.7K ﹤0.01% 2222
2022
Q3 		$100K Hold
10,097
– – ﹤0.01% 2223
2022
Q2 		$92K Hold
10,097
– – ﹤0.01% 2300
2022
Q1 		$102K Sell
10,097
-838
-8% -$8.6K ﹤0.01% 2272
2021
Q4 		$182K Buy
10,935
+2,900
+36% +$123K ﹤0.01% 2126
2021
Q3 		$377K Sell
8,035
-10
-0.1% -$536 ﹤0.01% 1479
2021
Q2 		$490K Buy
8,045
+3,050
+61% +$174K ﹤0.01% 1238
2021
Q1 		$308K Buy
+4,995
New +$327K ﹤0.01% 1527

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Zurich Cantonal Bank's BBIO Position: Q2 2026 in Review

Zurich Cantonal Bank increased its BridgeBio Pharma (BBIO) stake by 12% in Q2 2026, buying an estimated $554K and bringing the position to 73,893 shares worth $5.5M. The position accounts for 0.01% of the portfolio, ranked #663.

Zurich Cantonal Bank first reported a position in BBIO in Q1 2021 and has held it in 22 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Zurich Cantonal Bank held 73,893 shares of BridgeBio Pharma worth $5.5M as of Q2 2026.
  • Zurich Cantonal Bank bought 7,906 BridgeBio Pharma shares in Q2 2026, an estimated $554K.
  • BridgeBio Pharma made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #663 holding.
  • Zurich Cantonal Bank first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 22 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.